Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk.
about
COX-2 protects against atherosclerosis independently of local vascular prostacyclin: identification of COX-2 associated pathways implicate Rgl1 and lymphocyte networks.A2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux.Regulation of foam cells by adenosine.ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.No association of nineteen COX-2 gene variants to preclinical markers of atherosclerosis The Cardiovascular Risk in Young Finns Study.Methotrexate in atherogenesis and cholesterol metabolismTreatment of rheumatoid arthritis with marine and botanical oils: influence on serum lipids.HDL function and subclinical atherosclerosis in juvenile idiopathic arthritis.Nonselective nonsteroidal antiinflammatory drugs and cardiovascular risk: are they safe?Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophagesPlasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular diseaseA novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors.COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophages.ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin-1-dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone
P2860
Q33699097-D7D2AF6C-C874-430C-A750-603092C2EECFQ33805277-3AB59854-7E2A-41DD-AD67-C03B0190EA61Q34031160-0540C23D-16C2-44C0-AE50-1FE67F8878E4Q34112680-2EE140E3-44AD-4213-8FCE-6A496D7A097FQ34253730-C7D6765A-5700-4475-9F01-0BB7747F08EBQ34757801-7254428D-0539-4769-9CE3-9A68E9DA259AQ35295398-AE33F27A-007F-4C90-AD80-AA581C8AD8F4Q36516383-147E8716-ED1C-422A-90B9-32ADEB5923D7Q36869571-0ED38C49-4EF9-4AF4-979D-FFA08BFCE16BQ37008144-40542DA3-C2EA-4291-89F2-28473E6F90E8Q37078045-4180E8DA-EEAA-44CE-A1D0-94B2299EA0F3Q37239559-64EE14EB-E5AA-4624-BB3E-DCF1B4E480BAQ48166277-B8EA2156-6C12-4AD8-9828-2956AA901BB9Q58729525-5ED6281B-E764-49F9-A05E-CCFF4278C94A
P2860
Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Effect of cyclooxygenase inhib ...... increased cardiovascular risk.
@ast
Effect of cyclooxygenase inhib ...... increased cardiovascular risk.
@en
type
label
Effect of cyclooxygenase inhib ...... increased cardiovascular risk.
@ast
Effect of cyclooxygenase inhib ...... increased cardiovascular risk.
@en
prefLabel
Effect of cyclooxygenase inhib ...... increased cardiovascular risk.
@ast
Effect of cyclooxygenase inhib ...... increased cardiovascular risk.
@en
P2093
P2860
P356
P1476
Effect of cyclooxygenase inhib ...... increased cardiovascular risk
@en
P2093
Edwin S L Chan
Hongwei Zhang
Louis Ragolia
Patricia Fernandez
Sari D Edelman
Steven Carsons
Thomas Palaia
P2860
P2888
P356
10.1186/AR2109
P577
2007-01-01T00:00:00Z
P5875
P6179
1003078583